| scholarly article | Q13442814 |
| P50 | author | Xuping Xie | Q54118103 |
| Laura D Kramer | Q56450083 | ||
| Pei-Yong Shi | Q59435668 | ||
| P2093 | author name string | Min Qing | |
| Zhiming Yuan | |||
| Hao Ying Xu | |||
| Qing-Yin Wang | |||
| P2860 | cites work | A small-molecule dengue virus entry inhibitor | Q22309806 |
| Inhibition of interferon signaling by dengue virus | Q24630622 | ||
| The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids | Q27469354 | ||
| Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay. | Q27469439 | ||
| Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. | Q27469704 | ||
| Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses | Q27469841 | ||
| Structure of the Dengue Virus Helicase/Nucleoside Triphosphatase Catalytic Domain at a Resolution of 2.4 A | Q27470453 | ||
| An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization | Q27472613 | ||
| Mutations in the Yellow Fever Virus Nonstructural Protein NS2A Selectively Block Production of Infectious Particles | Q27472873 | ||
| Infectious cDNA clone of the epidemic west nile virus from New York City | Q27472878 | ||
| Triaryl pyrazoline compound inhibits flavivirus RNA replication | Q27473130 | ||
| West Nile Virus 5'-Cap Structure Is Formed by Sequential Guanine N-7 and Ribose 2'-O Methylations by Nonstructural Protein 5 | Q27477465 | ||
| Molecular and Functional Analyses of Kunjin Virus Infectious cDNA Clones Demonstrate the Essential Roles for NS2A in Virus Assembly and for a Nonconservative Residue in NS3 in RNA Replication | Q27477562 | ||
| Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro | Q27480361 | ||
| trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication | Q27485867 | ||
| Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity | Q27486196 | ||
| Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites | Q27486606 | ||
| Exclusion of West Nile Virus Superinfection through RNA Replication | Q27490309 | ||
| An adenosine nucleoside inhibitor of dengue virus | Q27490481 | ||
| Identification of Hepatitis C Virus NS5A Inhibitors | Q27490539 | ||
| Small Molecule Inhibitors That Selectively Block Dengue Virus Methyltransferase | Q27666321 | ||
| Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity | Q28276481 | ||
| Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins | Q29620712 | ||
| West Nile virus inhibits the signal transduction pathway of alpha interferon | Q33718537 | ||
| A fluorescence-based alkaline phosphatase-coupled polymerase assay for identification of inhibitors of dengue virus RNA-dependent RNA polymerase | Q33789790 | ||
| Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect | Q34022149 | ||
| Strategies for development of Dengue virus inhibitors | Q34091777 | ||
| Functional analysis of two cavities in flavivirus NS5 polymerase | Q34800273 | ||
| A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease. | Q38912795 | ||
| Higher catalytic efficiency of N-7-methylation is responsible for processive N-7 and 2'-O methyltransferase activity in dengue virus | Q38947082 | ||
| Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing | Q39301197 | ||
| Inhibition of dengue virus polymerase by blocking of the RNA tunnel | Q39306357 | ||
| A high-throughput assay using dengue-1 virus-like particles for drug discovery | Q39373894 | ||
| Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA. | Q39541510 | ||
| Development and characterization of a stable luciferase dengue virus for high-throughput screening | Q39541700 | ||
| N-sulfonylanthranilic acid derivatives as allosteric inhibitors of dengue viral RNA-dependent RNA polymerase | Q39616455 | ||
| Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors. | Q39616465 | ||
| Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead | Q39616471 | ||
| The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner | Q40174839 | ||
| Studies on avian infectious bronchitis virus (IBV). III. Interferon induction by and sensitivity to interferon of IBV. | Q40272135 | ||
| Subcellular localization and membrane topology of the Dengue virus type 2 Non-structural protein 4B. | Q40325204 | ||
| A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4. | Q40553373 | ||
| De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase | Q40596948 | ||
| The NS 3 nonstructural protein of flaviviruses contains an RNA triphosphatase activity | Q41517814 | ||
| The carboxy-terminal part of the NS 3 protein of the West Nile Flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase | Q42985863 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Dengue virus | Q476209 |
| Chikungunya virus | Q15794049 | ||
| P304 | page(s) | 11183-11195 | |
| P577 | publication date | 2011-08-24 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Inhibition of dengue virus by targeting viral NS4B protein | |
| P478 | volume | 85 |
| Q35758578 | A Combined Genetic-Proteomic Approach Identifies Residues within Dengue Virus NS4B Critical for Interaction with NS3 and Viral Replication |
| Q37415438 | A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein. |
| Q35022038 | A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease |
| Q36505563 | A novel inhibitor of dengue virus replication that targets the capsid protein |
| Q38866173 | An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection |
| Q35647755 | Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase |
| Q55277816 | Biochemistry and Molecular Biology of Flaviviruses. |
| Q40279649 | Bioinformatics prediction of siRNAs as potential antiviral agents against dengue viruses |
| Q29994527 | Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond |
| Q35487910 | Characterization of dengue virus NS4A and NS4B protein interaction |
| Q115215852 | Compartmentalized replication organelle of flavivirus at the ER and the factors involved |
| Q86939020 | Computer-Assisted and Data Driven Approaches for Surveillance, Drug Discovery, and Vaccine Design for the Zika Virus |
| Q39249833 | Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection |
| Q115234716 | Dengue Virus NS4b N-Terminus Disordered Region Interacts with NS3 Helicase C-Terminal Subdomain to Enhance Helicase Activity |
| Q90825369 | Dengue drug discovery: Progress, challenges and outlook |
| Q28542607 | Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions |
| Q54232092 | Dengue virus NS2 and NS4: Minor proteins, mammoth roles. |
| Q57283594 | Dengue virus and the host innate immune response |
| Q28085044 | Dengue: an update on treatment options |
| Q35760466 | Determinants of Dengue Virus NS4A Protein Oligomerization |
| Q37643762 | Dimerization of flavivirus NS4B protein |
| Q35643850 | Discovery of Dengue Virus NS4B Inhibitors |
| Q36730021 | Escape Mutations in NS4B Render Dengue Virus Insensitive to the Antiviral Activity of the Paracetamol Metabolite AM404 |
| Q101116526 | Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness |
| Q36586306 | Experimental therapies for yellow fever |
| Q26314693 | Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral intervention |
| Q115215932 | Flavivirus NS4B protein: Structure, function, and antiviral discovery |
| Q37123525 | Flaviviruses are sensitive to inhibition of thymidine synthesis pathways |
| Q39255013 | Generation and characterization of mouse monoclonal antibodies against NS4B protein of dengue virus |
| Q28486302 | High content screening of a kinase-focused library reveals compounds broadly-active against dengue viruses |
| Q89334699 | High-throughput screening (HTS) for the identification of novel antiviral scaffolds |
| Q35742387 | Identification of dengue viral RNA-dependent RNA polymerase inhibitor using computational fragment-based approaches and molecular dynamics study |
| Q59000638 | Immunogenicity of NS4b Dengue 3 Virus Mimotope Presented to the Immune System as Multiple Antigen Peptide System |
| Q38096721 | Intervention strategies for emerging viruses: use of antivirals |
| Q34246661 | Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug |
| Q39633694 | Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors |
| Q37057168 | Luminescent multiplex viability assay for Trypanosoma brucei gambiense |
| Q35488254 | Mapping the Interactions between the NS4B and NS3 proteins of dengue virus |
| Q27676369 | Membrane Topology and Function of Dengue Virus NS2A Protein |
| Q35745411 | Mutation of Putative N-Glycosylation Sites on Dengue Virus NS4B Decreases RNA Replication |
| Q28548514 | Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase |
| Q34206832 | Novel approaches to flavivirus drug discovery |
| Q114704016 | Novel insights into the function of an N-terminal region of DENV2 NS4B for the optimal helicase activity of NS3 |
| Q114704018 | On track to tackle dengue: History and future of NS4B ligands |
| Q38953548 | Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus |
| Q39017020 | Peptide inhibitors against dengue virus infection. |
| Q35747460 | Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells |
| Q24700044 | Predicting Zika virus structural biology: Challenges and opportunities for intervention |
| Q37566687 | Replication cycle and molecular biology of the West Nile virus |
| Q58099567 | Research Models and Tools for the Identification of Antivirals and Therapeutics against Zika Virus Infection |
| Q26860307 | Role of microparticles in dengue virus infection and its impact on medical intervention strategies |
| Q38156719 | Screening of FDA-Approved Drugs for Inhibitors against Japanese Encephalitis Virus Infection |
| Q38045106 | Structural biology of dengue virus enzymes: towards rational design of therapeutics |
| Q90737186 | Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus |
| Q38916167 | Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors |
| Q56353961 | The A-Z of Zika drug discovery |
| Q115234654 | The Biogenesis of Dengue Virus Replication Organelles Requires the ATPase Activity of Valosin-Containing Protein |
| Q54557957 | The Dengue Virus Replication Complex: From RNA Replication to Protein-Protein Interactions to Evasion of Innate Immunity. |
| Q34923354 | The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication |
| Q28655818 | The citrus flavanone naringenin impairs dengue virus replication in human cells |
| Q40250047 | The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase. |
| Q34991051 | Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly |
| Q37666750 | West Nile virus drug discovery |
| Q27928069 | Zika Virus Replicons for Drug Discovery |
Search more.